Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD109 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SH2D4A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | PMVK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | OR6T1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ABAT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KCNK16 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | UBLCP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RAPGEF4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EIF3A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZBTB44 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |